Janney Montgomery Scott LLC Reduces Stock Position in Genpact Limited (NYSE:G)

Janney Montgomery Scott LLC lessened its holdings in shares of Genpact Limited (NYSE:GFree Report) by 20.5% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 12,667 shares of the business services provider’s stock after selling 3,276 shares during the period. Janney Montgomery Scott LLC’s holdings in Genpact were worth $638,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Atlas Capital Advisors Inc. boosted its stake in shares of Genpact by 55.8% during the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider’s stock valued at $26,000 after purchasing an additional 216 shares in the last quarter. Stifel Financial Corp grew its holdings in shares of Genpact by 1.0% during the 4th quarter. Stifel Financial Corp now owns 30,821 shares of the business services provider’s stock worth $1,324,000 after acquiring an additional 291 shares during the period. Fifth Third Bancorp raised its position in shares of Genpact by 9.5% in the 1st quarter. Fifth Third Bancorp now owns 3,461 shares of the business services provider’s stock worth $174,000 after acquiring an additional 299 shares in the last quarter. OneAscent Wealth Management LLC raised its position in shares of Genpact by 5.5% in the 4th quarter. OneAscent Wealth Management LLC now owns 8,380 shares of the business services provider’s stock worth $360,000 after acquiring an additional 439 shares in the last quarter. Finally, ProShare Advisors LLC lifted its stake in shares of Genpact by 6.2% in the 4th quarter. ProShare Advisors LLC now owns 7,591 shares of the business services provider’s stock valued at $326,000 after purchasing an additional 445 shares during the period. Institutional investors own 96.03% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the company. Needham & Company LLC reaffirmed a “buy” rating and issued a $50.00 price target on shares of Genpact in a research note on Monday. Wall Street Zen raised shares of Genpact from a “buy” rating to a “strong-buy” rating in a research report on Friday, June 6th. Mizuho upped their price objective on Genpact from $48.00 to $51.00 and gave the company a “neutral” rating in a research report on Tuesday. Finally, Robert W. Baird cut their target price on Genpact from $56.00 to $50.00 and set a “neutral” rating on the stock in a research note on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $50.14.

View Our Latest Analysis on Genpact

Insider Activity

In other Genpact news, Director Nicholas C. Gangestad bought 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 13th. The shares were bought at an average price of $43.97 per share, with a total value of $87,940.00. Following the purchase, the director owned 2,000 shares of the company’s stock, valued at $87,940. This trade represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 2.80% of the stock is currently owned by company insiders.

Genpact Trading Up 2.2%

NYSE:G opened at $44.97 on Wednesday. The company has a market cap of $7.86 billion, a PE ratio of 15.35, a price-to-earnings-growth ratio of 1.66 and a beta of 0.94. The company has a current ratio of 2.45, a quick ratio of 2.45 and a debt-to-equity ratio of 0.48. The company has a 50 day simple moving average of $44.44 and a two-hundred day simple moving average of $46.90. Genpact Limited has a 12 month low of $30.38 and a 12 month high of $56.76.

Genpact (NYSE:GGet Free Report) last issued its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.84 EPS for the quarter, topping the consensus estimate of $0.80 by $0.04. Genpact had a return on equity of 22.35% and a net margin of 10.88%. The company had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. During the same quarter in the previous year, the company posted $0.73 earnings per share. Genpact’s revenue was up 7.4% compared to the same quarter last year. Research analysts forecast that Genpact Limited will post 3.21 earnings per share for the current year.

Genpact Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, June 30th. Shareholders of record on Wednesday, June 18th were paid a dividend of $0.17 per share. This represents a $0.68 dividend on an annualized basis and a yield of 1.51%. The ex-dividend date of this dividend was Wednesday, June 18th. Genpact’s payout ratio is 23.21%.

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Further Reading

Institutional Ownership by Quarter for Genpact (NYSE:G)

Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.